Clinical Trial Update: S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer [Phase 2]

View source ↗

Summary

The SWOG S9720 phase 2 trial evaluating a combination chemotherapy regimen in metastatic, recurrent, or refractory endometrial cancer has completed. This clinic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• S9720

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED